Natural and Engineered Bacteriophage as Adjuvants for Antibiotic Therapy

The Portal is a joint project of MATTO and the MTTC. The development and implementation of the portal has been paid for by the MTTC, Beth Israel Deaconess Medical Center, Boston Biomedical Research Institute, Boston University, Brandeis University, Caritas St. Elizabeth's Medical Center, Boston Children's Hospital, Dana Farber Cancer Institute, Harvard University, Joslin Diabetes Center, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, McLean Hospital, Northeastern University, The Schepens Eye Research Institute, and Tufts University.

Intellectual Property

ID:		07-61
IP Type:		Licensable Technology
Title:		Natural and Engineered Bacteriophage as Adjuvants for Antibiotic Therapy
Inventor:		Collins, James J
Summary:		General concept of combining engineered phage with antibiotics to enhance antibiotic activity. Engineered phage would likely dissolve biofilms (and possibly to destroy the bacterial cell), which will allow antibiotics to enter the bacterial cell.
Tech Type:		Therapeutics - Drugs
URL:		http://ctf-fmfe.bu.edu/NoPDF.htm
Contact:		Hong Xu, rclark@bu.edu, 617 358 4208
Organization:		Boston University

Display all intellectual properties for Collins, James J
Display all intellectual properties for Boston University